Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VANCOCIN HYDROCHLORIDE | ANI Pharmaceuticals | N-050606 RX | 1986-04-15 | 2 products, RLD, RS |
FIRVANQ KIT | Azurity | N-208910 RX | 2018-01-26 | 2 products, RLD, RS |
VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER | Baxter | N-050671 RX | 1993-04-29 | 5 products, RLD, RS |
VANCOMYCIN HYDROCHLORIDE | Hikma Pharmaceuticals | N-211962 RX | 2019-02-15 | 7 products, RLD, RS |
VANCOMYCIN HYDROCHLORIDE | Mylan | N-209481 RX | 2018-07-10 | 5 products, RLD, RS |
VANCOMYCIN HYDROCHLORIDE | Zhejiang Novus Pharmaceuticals | N-210274 RX | 2023-01-20 | 4 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VANCOMYCIN | Hikma Pharmaceuticals | N-213895 DISCN | 2021-08-26 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
firvanq | New Drug Application | 2023-12-08 |
sterile vancomycin hydrochloride | ANDA | 2010-12-22 |
vancocin | New Drug Application | 2024-07-31 |
vancomycin | ANDA | 2024-07-19 |
vancomycin hcl | unapproved drug other | 2014-08-20 |
vancomycin hydrochloride | ANDA | 2025-01-16 |
vancomycin hydrochloride for oral solution | NDA authorized generic | 2023-02-28 |
vancomycin hydrochloride vancomycin hydrochloride | ANDA | 2021-07-19 |
Expiration | Code | ||
---|---|---|---|
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, ALKEM LABS LTD | |||
2024-02-25 | PC | ||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, HIKMA | |||
2024-02-12 | CGT | ||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, AMNEAL | |||
2023-12-20 | CGT |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Vancomycin, Vancomycin, Xellia Pharms Aps | |||
10039804 | 2035-11-06 | DP | U-282 |
10188697 | 2035-11-06 | DP | U-282 |
10849956 | 2035-11-06 | DP | |
11000567 | 2035-11-06 | DP | |
11517609 | 2035-11-06 | U-282 | |
Vancomycin Hydrochloride, Vancomycin Hydrochloride, Xellia Pharms Aps | |||
11628200 | 2035-11-06 | DP | |
Vancomycin Hydrochloride, Firvanq Kit, Azurity | |||
10493028 | 2035-03-13 | DP | |
10688046 | 2035-03-13 | DP | |
10959946 | 2035-03-13 | DP | |
10959947 | 2035-03-13 | DP | U-3104, U-3105 |
10959948 | 2035-03-13 | DP | U-3104, U-3105 |
10959949 | 2035-03-13 | DP | U-3104, U-3105 |
11638692 | 2035-03-13 | DP |
Drug common name | Vancomycin |
INN | vancomycin |
Description | Vancomycin is a complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile. It has a role as an antimicrobial agent, an antibacterial drug and a bacterial metabolite. It is functionally related to a vancomycin aglycone. It is a conjugate base of a vancomycin(1+). |
Classification | Small molecule |
Drug class | antibiotics (Streptomyces strain) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O |
PDB | — |
CAS-ID | 1404-90-6 |
RxCUI | — |
ChEMBL ID | CHEMBL262777 |
ChEBI ID | 28001 |
PubChem CID | 14969 |
DrugBank | DB00512 |
UNII ID | 6Q205EH1VU (ChemIDplus, GSRS) |